Talk details: 

O2M was founded in Feb 2017 to commercialize electron paramagnetic resonance oxygen imaging (EPROI) technology. Oxygen is a fundamental physiological parameter and affects all aspects of living tissues. Even though it was known that hypoxia impacts the therapy outcome in cancer, type I diabetes, and many other pathologies, there was no commercially available system for oxygen imaging that could be utilized for therapy guidance. This led us to start the commercialization efforts of EPROI via O2M. Bringing a new technology from a lab to the marketplace is like giving birth and raising a child and sending them to the world, many ups and downs, but never too boring.
In this talk, she will use her experience of starting and running O2M as a case study to discuss various aspects of entrepreneurship and the biotech startup echo system. She will talk about my motivation for moving from academia to industry and my journey since then. I will discuss the joy and fulfillment as well as the challenges of growing an entity. I will discuss the technical, legal, financial, and intellectual property fronts of managing a business.